Navigation Links
Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
Date:5/13/2008

Support for Grassley-Kohl Bill Newest Addition to Lilly's 'Transparency

Agenda'

INDIANAPOLIS, May 13 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY) announced its support of the newly revised Physicians Payments Sunshine Act, sponsored by United States Senators Charles Grassley (R-Iowa) and Herbert Kohl (D-Wisconsin). The bipartisan bill would establish a national registry of payments to physicians by medical device, medical supply and pharmaceutical companies. Lilly is the first pharmaceutical research company to back such federal legislation, which is similar to various laws in place in several states.

"Lilly welcomes greater transparency in the health care system and believes this legislation represents an important step in building public trust and confidence in the relationships between the pharmaceutical and device industries and physicians," said John C. Lechleiter, Ph.D., president and chief executive officer of Eli Lilly and Company. "Lilly intends to continue to build upon its leadership position in transparency. In addition to our publicly available clinical trial and educational grant registries, we continue to look at other ways to open up our business to the public. This will help provide the assurance that Lilly runs its business consistent not only with our principles, but with the principles that a healthcare provider or patient should expect from a pharmaceutical company."

Noting the benefits of the federal standard for reporting payments to doctors, Lechleiter added, "A key strength of the Grassley-Kohl bill is that it would create a uniform national standard for reporting physician payments. This helps patients, businesses and doctors alike by sett
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
2. Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
3. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
4. Lilly Reports Solid First-Quarter Results
5. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
6. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
7. Lilly Announces Termination of AIR Insulin Program
8. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
9. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
10. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
11. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi Pharma...echnology, and medical-device research and,develop...and the United States,announced that it had been ...2009 list for the fifth consecutive year. The list...ina,s technology, media, and telecommunications,in...
(Date:11/28/2009)... The Vanuatu National Advisory Committee on Cl...ommunication (SNC) Project in collaboration with t... Ltd. of New Zealand have generated preliminary cl...form the background for the country’s SNC re... on Climate Change (UNFCCC). , ...
(Date:11/26/2009)... Ind. - A new generation of ultrasmall transistors...tures called semiconducting nanowires are closer t...IBM, Purdue University and the University of Calif...rned how to create nanowires with layers of differ...ic level, which is a critical requirement for maki...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 25 /PRNews...ful year. Not so for BodyLogicMD. The nation,s la...ians specializing exclusively in medically supervi...of physicians in its network since November ...ess to add more physician-owned centers, including...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
...l 1, 2009, Xmark Opportunity Partners, LLC, the so...tunity Fund, L.P. and Xmark Opportunity Fund, Ltd....ors of Icagen, Inc. (Nasdaq: ICGN ). , , ...C, 90 Grove Str...01, Ridgefield, Connec...
...ed pro-t-action(TM) product based on probiotic mic...ed into consumer products for daily oral care , ,... Association of Dental Research annual conference ...Germany and MIAMI, April 1 With an eye to help re...mated 5 billion people world-wide, BASF -- The Che...
...all/ - SemBioSys Genetics Inc. (TSX:SBS), speciali... oils in plant seeds, provides an update on its pr... program. In December 2008, SemBioSys announced th... option to license rights to SemBioSys, proprietar...sed primarily for AFRESA(TM), MannKind,s ultra-rap...
Other Biology Technology:Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign 2BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 2BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 3BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 4BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 5SemBioSys provides update on insulin program 2SemBioSys provides update on insulin program 3
(Date:11/30/2009)...ress of seeing your extended family over the holid... report in the December 2009 print issue of the J....org ) shows that you might be right. Here,s the g...o entirely new treatments that help keep autoimmun... control. That,s because researchers from the Univ...
(Date:11/26/2009)...e antlers, red deer have been caught in the hunter...e much more than decorative. They are lethal weapo...urrey, from The University of York, UK, has been i...over half a century and has become fascinated by t...standing collaboration with Tomas Landete-Castille...
(Date:11/26/2009)...t Staphylococcus Aureus ) and other drug-resistan...ure plasma prototype devices have been developed t...al cocktails. , Two prototype devices have been ...hy skin (e.g. hands and feet) in hospitals and pub...; and another to shoot bacteria-killing agents int...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment and P 12687 1Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment and P 12687 2Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment and P 12687 3Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx 28R 29 GENTAMICIN TOPICAL for the Treatment and P 12687 4Sanford Installs New Low Dose CT Technology 49320 1Sanford Installs New Low Dose CT Technology 49320 2Sanford Installs New Low Dose CT Technology 49320 3Bariatric Advantage Will Be in Attendance at the 26th Annual American Society of Metabolic and Bariatric Surgery in Dallas Texas 49316 1Bariatric Advantage Will Be in Attendance at the 26th Annual American Society of Metabolic and Bariatric Surgery in Dallas Texas 49316 2
...ia, San Francisco (UCSF) have discovered a gene mu...lcohol. The findings, reported in the October 6 is... human studies seeking to understand innate differ...rch was supported by the National Institute on Alc... Institute on Drug Abuse (NIDA) of the National In...
... genes linked to breast cancer can accurately asse...ing to an article in the September 6 issue of the ...vious research, scientists at the Netherlands Canc...ociated with patient outcomes in a group of patien...cm. The 231 genes were reduced to a core group of ...
...t flies can be demonstrated by the influx of calci...curs after special training that includes periods ...edicine (BCM) in a report that appears in the curr... evidence that this is really a molecular change t...ald Davis, professor of molecular and cellular bio...
Other Biology News:Fruit fly study identifies gene mutation that regulates sensitivity to alcohol 2Gene signature assesses breast cancer outcomes 2
...P-165 is an 18 amino acid synthetic peptide whose ... The sequence of this peptide is (amino to carbox... - E - A - I - D - K - K - I - K - Q - D - C(39). ...control experiments with the polyclonal antibody t...
...stom peptide microarrays designed for quantitative...erum samples and built on the flexible and powerfu...ds of customer specified sequences can be synthesi... with custom sequence design. These microarrays ar...
...utralizing synthetic peptide for OPA1-01009, OPEP-...tic peptide whose sequence is from human DNA fragm...de is (amino to carboxy terminus): Q(3) - K - P - ...18). This peptide may be used for neutralization...
...emicon Select Tissue Arrays are intended for labor...ere fixed in neutral buffered formalin and embedde...s was performed by certified pathologists. Tissue... relocated into a new recipient paraffin block, in...
Biology Products: